Resmed (RSMDF) Intangibles (2010 - 2026)
Resmed's (RSMDF) quarterly Intangibles came in at $452.7 million in Q2 2026, down 2.61% on a YoY basis from $464.9 million in Q2 2025, and up 6.48% quarter-over-quarter from $425.2 million in Q1 2026.
Analysis
Resmed (RSMDF) Intangibles (2010 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Intangibles for 16 consecutive years, with $452.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Intangibles fell 2.61% year-over-year to $452.7 million; the trailing twelve-month figure through Jun 2026 stood at $452.7 million (down 2.61% YoY), and the FY2026 full-year result was $452.7 million, down 2.61% from the prior year.
- Intangibles advanced to $452.7 million in Q2 2026 per RSMDF's latest filing, from $425.2 million in the prior quarter.
- Across five years, Intangibles topped out at $586.9 million in Q4 2022 and bottomed at $338.2 million in Q3 2022.
- Historically, Intangibles has averaged $466.3 million across 5 years, with a median of $458.8 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Intangibles jumped 66.58% in 2023, then declined 17.07% in 2024.
- Over 5 years, Intangibles stood at $586.9 million in 2022, then decreased by 10.0% to $528.2 million in 2023, then declined by 17.07% to $438.0 million in 2024, then fell by 1.77% to $430.2 million in 2025, then gained by 5.23% to $452.7 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $452.7 million, $425.2 million, and $430.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.44 Bn | 177.84 Bn | 7.27 Bn | 17.21 Bn |
| 2 | Intuitive Surgical | 124.34 Bn | 119.12 Bn | 1.96 Bn | 1.14 Bn |
| 3 | Medtronic | 118.30 Bn | 109.49 Bn | 6.34 Bn | 10.24 Bn |
| 4 | Stryker | 106.55 Bn | 103.07 Bn | 4.50 Bn | 5.74 Bn |
| 5 | Boston Scientific | 66.56 Bn | 66.02 Bn | 3.85 Bn | 6.92 Bn |
| 6 | Edwards Lifesciences | 49.55 Bn | 45.30 Bn | 1.35 Bn | 1.38 Bn |
| 7 | Alcon | 33.95 Bn | 32.49 Bn | 1.68 Bn | 8.27 Bn |
| 8 | Dexcom | 32.04 Bn | 30.10 Bn | 830.00 Mn | 101.60 Mn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | 1.56 Bn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 452.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 452.74 Mn |
| Mar 31, 2026 | 425.19 Mn |
| Dec 31, 2025 | 430.24 Mn |
| Sep 30, 2025 | 447.07 Mn |
| Jun 30, 2025 | 464.86 Mn |
| Mar 31, 2025 | 430.11 Mn |
| Dec 31, 2024 | 438.00 Mn |
| Sep 30, 2024 | 478.61 Mn |
| Jun 30, 2024 | 485.90 Mn |
| Mar 31, 2024 | 501.02 Mn |
| Dec 31, 2023 | 528.18 Mn |
| Sep 30, 2023 | 563.28 Mn |
| Jun 30, 2023 | 552.34 Mn |
| Mar 31, 2023 | 569.68 Mn |
| Dec 31, 2022 | 586.86 Mn |
| Sep 30, 2022 | 338.15 Mn |
| Jun 30, 2022 | 345.94 Mn |
| Mar 31, 2022 | 355.98 Mn |
| Dec 31, 2021 | 372.01 Mn |
| Sep 30, 2021 | 375.40 Mn |